APA (7th ed.) Citation

Calvo-Gutiérrez, J., López-Medina, C., Otero-Varela, L., Escudero-Contreras, A., Ortega-Castro, R., Ladehesa-Pineda, L., . . . Castrejón, I. (2024). Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry. Arthritis research & therapy, 26(1), 57-9. https://doi.org/10.1186/s13075-024-03287-9

Chicago Style (17th ed.) Citation

Calvo-Gutiérrez, Jerusalem, et al. "Impact of Multimorbidity on the First Ts/bDMARD Effectiveness and Retention Rate After Two Years of Follow-up in Patients with Rheumatoid Arthritis from the BIOBADASER Registry." Arthritis Research & Therapy 26, no. 1 (2024): 57-9. https://doi.org/10.1186/s13075-024-03287-9.

MLA (9th ed.) Citation

Calvo-Gutiérrez, Jerusalem, et al. "Impact of Multimorbidity on the First Ts/bDMARD Effectiveness and Retention Rate After Two Years of Follow-up in Patients with Rheumatoid Arthritis from the BIOBADASER Registry." Arthritis Research & Therapy, vol. 26, no. 1, 2024, pp. 57-9, https://doi.org/10.1186/s13075-024-03287-9.